Corindus Vascular Robotics Quick Ratio (CVRS) starting from the second quarter 2019 to second quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Corindus Vascular Robotics, Inc.  (CVRS)

Corindus Vascular Robotics's Quick Ratio

CVRS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2019, Quick Ratio fell to 2.44 below Corindus Vascular Robotics, Inc. average.

Within Medical Equipment & Supplies industry 60 other companies have achieved higher Quick Ratio than Corindus Vascular Robotics in second quarter 2019. While Quick Ratio total ranking in the second quarter 2019 has deteriorated compared to the prior quarter from 652 to 1075.

Explain Quick Ratio?
How much Cash & cash equivalents CVRS´s has?
What are CVRS´s Current Liabilities?




CVRS Quick Ratio (Jun 30 2019)
Q2
(Mar 31 2019)
Q1
(Dec 31 2018)
Q4
(Sep 30 2018)
Q3
(Jun 30 2018)
Q2
Y / Y Current Liabilities Change 122.25 % 48.11 % 32 % -10.92 % -21.28 %
Y / Y Cash & cash equivalent Change -7.41 % -14.36 % 36.22 % 13.95 % -1.59 %
Quick Ratio MRQ 2.44 4.04 2.81 5.05 5.87
CVRS's Total Ranking # 1075 # 652 # 735 # 582 # 1087
Seq. Current Liabilities Change 40.03 % 9.42 % 44.84 % 0.15 % -6.68 %
Seq. Cash & cash equivalent Change -15.3 % 57.4 % -19.41 % -13.82 % -21.66 %



Quick Ratio second quarter 2019 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 61
Healthcare Sector # 488
Overall Market # 1075


Quick Ratio Statistics
High Average Low
8.23 3.78 0
(Jun 30 2015)   (Dec 31 2013)




Financial Statements
Corindus Vascular Robotics's Current Liabilities $ 13 Millions Visit CVRS's Balance sheet
Corindus Vascular Robotics's Cash & cash equivalent $ 32 Millions Visit CVRS's Balance sheet
Source of CVRS's Sales Visit CVRS's Sales by Geography


Cumulative Corindus Vascular Robotics's Quick Ratio

CVRS's Quick Ratio for the trailling 12 Months

CVRS Quick Ratio

(Jun 30 2019)
12 Months
(Mar 31 2019)
12 Months
(Dec 31 2018)
12 Months
(Sep 30 2018)
12 Months
(Jun 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 45.8 % 10.39 % -12.13 % -20.27 % -22.01 %
Y / Y Cash & cash equivalent TTM Growth 0.93 % 2.55 % 6.85 % 9.06 % 13.82 %
Quick Ratio TTM 3.35 4.25 4.97 5.13 4.84
Total Ranking TTM # 881 # 319 # 4310 # 376 # 691
Seq. Current Liabilities TTM Growth 24.26 % 11.4 % 8.43 % -2.86 % -5.92 %
Seq. Cash & cash equivalent TTM Growth -2.03 % -4.78 % 5.06 % 2.98 % -0.45 %


On the trailing twelve months basis Due to jump in Current Liabilities in the Q2 2019 to $13.20 millions, cumulative Quick Ratio decreased to 3.35 below the Corindus Vascular Robotics, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 51 other companies have achieved higher Quick Ratio than Corindus Vascular Robotics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2019 from 319 to 881.

Explain Quick Ratio?
How much Cash & cash equivalents CVRS´s has?
What are CVRS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 52
Healthcare Sector # 443
Within the Market # 881


trailing twelve months Quick Ratio Statistics
High Average Low
6.29 4.32 0
(Sep 30 2015)   (Mar 31 2014)




Companies with similar Quick Ratio in the quarter ending Jun 30 2019, within Medical Equipment & Supplies Industry Quick RatioJun 30 2019 MRQ Cash & cash equivalentJun 30 2019 MRQ Current Liabilities
Iradimed Corporation  6.68 $ 32.422  Millions$ 4.857  Millions
Axogen inc   6.36 $ 103.063  Millions$ 16.214  Millions
Biolife Solutions Inc   6.34 $ 19.617  Millions$ 3.093  Millions
Transmedics Group Inc   6.33 $ 96.237  Millions$ 15.202  Millions
Electrocore Inc   6.11 $ 41.134  Millions$ 6.730  Millions
Invivo Therapeutics Holdings Corp   6.09 $ 9.902  Millions$ 1.627  Millions
Masimo Corp  5.99 $ 588.784  Millions$ 98.304  Millions
Perspective Therapeutics Inc   5.92 $ 5.326  Millions$ 0.899  Millions
Intersect Ent Inc   5.86 $ 93.472  Millions$ 15.953  Millions
Abiomed Inc   5.79 $ 486.672  Millions$ 84.008  Millions
Soliton Inc   5.66 $ 11.187  Millions$ 1.976  Millions
Neuronetics Inc   5.57 $ 89.644  Millions$ 16.091  Millions
Inogen Inc   5.52 $ 256.149  Millions$ 46.362  Millions
Soleno Therapeutics Inc  5.43 $ 15.503  Millions$ 2.855  Millions
Orasure Technologies Inc  4.91 $ 147.013  Millions$ 29.951  Millions
Glaukos Corp  4.85 $ 150.394  Millions$ 31.001  Millions
Myomo Inc   4.64 $ 6.669  Millions$ 1.436  Millions
Tactile Systems Technology Inc   4.26 $ 45.464  Millions$ 10.667  Millions
Valion Bio Inc   4.08 $ 4.674  Millions$ 1.145  Millions
Genmark Diagnostics Inc   3.84 $ 41.360  Millions$ 10.783  Millions
Nuvectra Corp  3.77 $ 69.764  Millions$ 18.487  Millions
Vapotherm Inc   3.64 $ 46.055  Millions$ 12.668  Millions
Staar Surgical Co  3.60 $ 103.251  Millions$ 28.711  Millions
Motus Gi Holdings Inc   3.59 $ 10.958  Millions$ 3.053  Millions
Owc Pharmaceutical Research Corp.  3.57 $ 1.840  Millions$ 0.516  Millions
Intuitive Surgical Inc   3.37 $ 2,718.400  Millions$ 807.500  Millions
Pro dex Inc   3.32 $ 10.391  Millions$ 3.131  Millions
Vivani Medical Inc   3.21 $ 25.161  Millions$ 7.838  Millions
Angiodynamics Inc   3.11 $ 227.641  Millions$ 73.302  Millions
Solana Company  3.04 $ 14.311  Millions$ 4.705  Millions

Date modified: 2026-09-26T06:50:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.